[go: up one dir, main page]

WO2001040801A3 - Diagnosis and treatment for helicobacter pylori induced colic - Google Patents

Diagnosis and treatment for helicobacter pylori induced colic Download PDF

Info

Publication number
WO2001040801A3
WO2001040801A3 PCT/US2000/032749 US0032749W WO0140801A3 WO 2001040801 A3 WO2001040801 A3 WO 2001040801A3 US 0032749 W US0032749 W US 0032749W WO 0140801 A3 WO0140801 A3 WO 0140801A3
Authority
WO
WIPO (PCT)
Prior art keywords
treatment
diagnosis
colic
helicobacter pylori
pylori induced
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2000/032749
Other languages
French (fr)
Other versions
WO2001040801A2 (en
Inventor
David H Willis Jr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Meridian Bioscience Inc
Original Assignee
Meridian Bioscience Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meridian Bioscience Inc filed Critical Meridian Bioscience Inc
Priority to AU19395/01A priority Critical patent/AU1939501A/en
Publication of WO2001040801A2 publication Critical patent/WO2001040801A2/en
Publication of WO2001040801A3 publication Critical patent/WO2001040801A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56922—Campylobacter
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/58—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving urea or urease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/62—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving urea
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/205—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Campylobacter (G)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/978—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • G01N2333/98—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in linear amides (3.5.1)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

The present invention provides a method for determining the cause of colic in infants and providing treatment therefor. In accordance with the method of the present invention, an infant exhibiting symptoms of colic is tested to determine if the symptoms could be attributable to an H.pylori induced infection and, if the test is positive, the infant is treated for the infection using an accepted treatment method.
PCT/US2000/032749 1999-12-03 2000-12-01 Diagnosis and treatment for helicobacter pylori induced colic Ceased WO2001040801A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU19395/01A AU1939501A (en) 1999-12-03 2000-12-01 Diagnosis and treatment for helicobacter pylori induced colic

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16892699P 1999-12-03 1999-12-03
US60/168,926 1999-12-03

Publications (2)

Publication Number Publication Date
WO2001040801A2 WO2001040801A2 (en) 2001-06-07
WO2001040801A3 true WO2001040801A3 (en) 2002-01-24

Family

ID=22613527

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/032749 Ceased WO2001040801A2 (en) 1999-12-03 2000-12-01 Diagnosis and treatment for helicobacter pylori induced colic

Country Status (2)

Country Link
AU (1) AU1939501A (en)
WO (1) WO2001040801A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI118061B (en) 2001-09-24 2007-06-15 Beanor Oy Procedure and bio donor for analysis
FI115166B (en) 2001-12-31 2005-03-15 Biofons Oy Diagnostic procedures

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998002572A1 (en) * 1996-07-15 1998-01-22 Gastro Services Pty. Limited Test strip for detecting gastric problems based on the presence of urease
US5716791A (en) * 1996-05-09 1998-02-10 Meridian Diagnostics, Inc. Immunoassay for H. pylori in fecal specimens

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5716791A (en) * 1996-05-09 1998-02-10 Meridian Diagnostics, Inc. Immunoassay for H. pylori in fecal specimens
WO1998002572A1 (en) * 1996-07-15 1998-01-22 Gastro Services Pty. Limited Test strip for detecting gastric problems based on the presence of urease

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
HUPPERTZ H -I ET AL: "Acute and chronic diarrhoea and abdominal colic associated with enteroaggregative Escherichia coli in young children living in western Europe.", LANCET (NORTH AMERICAN EDITION), vol. 349, no. 9066, 1997, pages 1660 - 1662, XP002940563, ISSN: 0099-5355 *
LEHTONEN LIISA ET AL: "Intestinal microflora in colicky and noncolicky infants: Bacterial cultures and gas-liquid chromatography.", JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, vol. 19, no. 3, 1994, pages 310 - 314, XP001011527, ISSN: 0277-2116 *
RAYMOND J ET AL: "[Prevalence of Helicobacter pylori infection in children according to their age. A retrospective study]. Prevalence de l'infection a Helicobacter pylori chez l'enfant en fonction de l'age: etude retrospective.", ARCHIVES DE PEDIATRIE, (1998 JUN) 5 (6) 617-20., XP001011528 *
THOMSON M: "Disorders of the oesophagus and stomach in infants.", BAILLIERES CLINICAL GASTROENTEROLOGY, (1997 SEP) 11 (3) 547-71. REF: 149, XP001011530 *

Also Published As

Publication number Publication date
WO2001040801A2 (en) 2001-06-07
AU1939501A (en) 2001-06-12

Similar Documents

Publication Publication Date Title
WO2003075745A3 (en) Detection, diagnosis, and monitoring of a medical condition or disease with artificial olfactometry
Gaffo et al. Effect of serum urate lowering with allopurinol on blood pressure in young adults: a randomized, controlled, crossover trial
DE69924749D1 (en) GENERICALLY INTEGRATED IMPLANT POTENTIOSTAT REMOTE MEASURING ARRANGEMENT FOR ELECTROCHEMICAL SENSORS
WO2003030731A3 (en) Method and apparatus for improving clinical accuracy of analyte measurements
WO2003041565A3 (en) Method for diagnosis of helicobacter pylori infection
WO1995024650A3 (en) Methods of diagnosing and treating preeclampsia
WO2003000117A3 (en) Detection and treatment of prostate cancer
WO2002041842A3 (en) Antibody pti-hs7 for treatment of alzheimer's disease and other amyloidoses and parkinson's disease
WO2001040801A3 (en) Diagnosis and treatment for helicobacter pylori induced colic
MIWA et al. Usefulness of the [13C]‐urea breath test for detection of Helicobacter pylori infection in fasting patients
Srilatha et al. Determination and Comparison of Dermatoglyphic Patterns and Salivary Streptococcus mutans Counts and Its Correlation with Dental Caries among 3-to 6-year-old Children.
DE602004017786D1 (en) COSEQUENCE FAULT DETECTION AND TREATMENT
Van den Neucker et al. Acid steatocrit: a reliable screening tool for steatorrhea
NO20025769D0 (en) Diagnosis of colic type in infants
WO1998046993A3 (en) Method for diagnosing cancer by measuring the presence of creatine kinase inhibitor
Vakil et al. Cost-Effectiveness of Noninvasive Testing and Treatment Strategies forH. pyloriInfection in Children With Dyspepsia
RU2001133138A (en) A method for the diagnosis of kidney condition in newborns
WO2002018633A3 (en) Determination of the ability of patients to respond to tumour treatment
Cho et al. Clinical and endoscopic findings in children with peptic ulcer in terms of Helicobacter pylori in Incheon
Chun et al. The clinical evaluation of selective neck dissection on tuberculouscervical lymphadenitis.
Miller Appropriate interval for assessing H. pylori eradication
UA36246A (en) Method for diagnosing and preparing undetected caries in approximate surfaces of molars below equator
ATE306699T1 (en) MEASURING DEVICE FOR DETECTING A PHYSIOLOGICAL MEASUREMENT SIZE
Shepherd et al. Childhood H. pylori: disappearing disease or chronic infection?
UA34280A (en) Method for determination of specific allergen

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP